InterventionsHumans50,009 participantsCohort study

GLP-1 Analogues and Long-term Outcomes in Adults with Obesity and Elevated CRP: A Real-world Matched Cohort Study

Figure 1 from The American Journal of Cardiology — Figure 1Shah et al.

The American Journal of Cardiology

The paper

Stuti Shah, Mohammed Abusafia, Hesham Sheashaa,

Shada Jadam, Susan Ospina, David C. Kaelber, Susan Keen, Leslie Cho,

Milind Y. Desai

Cleveland Clinic

The American Journal of Cardiology · 21 Sep 2026

doi.org/10.1016/j.amjcard.2026.09.016 PubMed 42767411

Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026